Skip to main content

Table 2 Clinical and demographic characteristics of 72 patients that underwent gastric resection or gastrectomy according to application of post-CTx

From: Original article: role of adjuvant chemotherapy in a perioperative chemotherapy regimen for gastric cancer

Characteristic

No adjuvant therapy (n = 20)

Adjuvant therapy (n = 52)

p-value

No.

%

No.

%

Gender

Male

12

60.0

36

69.2

0.457

Female

8

40.0

16

30.8

 

Age[y]

Median

64.19

59.89

0.052

Range

37.13 – 78.77

30.63 – 83.24

 

BMI

Median

24.9

25.6

0.817

Range

18.6 – 35.0

16.0 – 37.1

 

ASA

 

I

0

0.0

5

9.8

0.485

 

II

15

75.0

27

52.9

 

III

5

25.0

19

37.2

 

Medication

 Cortisone

yes

0

0.0

0

0.0

-

no

20

100.0

52

100.0

 

 IS

yes

0

0.0

2

3.8

0.374

no

20

100.0

50

96.2

 

 HTN

yes

11

55.0

23

44.4

0.953

no

9

45.0

29

55.8

 

Comorbidities

 DM

no

19

95.0

46

88.5

 

NIDDM

1

5.0

6

11.5

0.402

IDDM

0

0.0

0

0.0

 

 CHD

yes

1

5.0

6

11.5

0.402

no

19

95.0

46

88.5

 

Cirrhosis Child A

 

0

0.0

0

0.0

-

no

20

100

52

100.0

 

 COPD

yes

0

0.0

0

0.0

-

no

20

100.0

52

100.0

 

Primary tumor location

 AEG II

 

10

50.0

12

23.1

 

 AEG III

 

1

5.0

7

13.5

0.222

 Corpus

 

6

30.0

18

34.6

 Pylorus

 

3

15.0

14

26.9

 

 unknown

 

0

0

1

1.9

 

ypUICC-Stage

      

 0

 

1

5.0

7

13.5

 

 I

 

8

40.0

17

32.7

0.733

 II

 

5

25.0

11

21.2

 III

 

6

30.0

17

32.7

 

ypT-Stage

 0

 

2

10.0

7

13.5

 

 1

 

3

15.0

10

19.2

0.120

 2

 

7

35.0

12

23.1

 3

 

4

20.0

21

40.4

 

 4

 

4

20.0

2

3.8

 

ypN-Stage

 0

 

12

60.0

32

61.5

 

 1

 

6

30.0

14

26.9

0.237

 2

 

0

0

5

9.6

 

 3

 

2

10.0

1

1.9

 

ypM-Stage

 0

 

20

100

50

96.2

0.374

 x

 

0

0

2

3.8

 

Histological type

 diffuse

 

5

25.0

18

34.6

 

 intestinal

 

7

35.0

19

36.5

0.743

 mixtype

 

1

5.0

1

1.9

 

 unknown

 

7

35.0

14

26.9

 
  1. CHD coronary heart disease, AEG adenocarcinoma of the esophageal-gastric junction, HTN hypertension